4.8 Article

Au2Pt-PEG-Ce6 nanoformulation with dual nanozyme activities for synergistic chemodynamic therapy/phototherapy

Journal

BIOMATERIALS
Volume 252, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2020.120093

Keywords

Au2Pt-PEG-Ce6; Nanozymes; Synergistic therapy; Tri-modal imaging

Funding

  1. National Natural Science Foundation of China [51872263, 51772142, 51929201, 51720105015, 51672268]
  2. Science and Technology Cooperation Project between Chinese and Australian Governments [2017YFE0132300]
  3. Youth Innovation Promotion Association of CAS [2017273]
  4. Taishan Scholars Project of Shandong Province [ts20190911]
  5. Zhejiang Provincial Natural Science Foundation of China [LZ19E020001, LQ18B010002]
  6. Guangdong Natural Science Foundation of China [2019A1515012214]

Ask authors/readers for more resources

Although synergistic therapy for tumors has displayed significant promise for effective treatment of cancer, developing a simple and effective strategy to build a multi-functional nanoplatform is still a huge challenge. By virtue of the characteristics of tumor microenvironment, such as hypoxia, slight acidity and H2O2 overexpression, Au2Pt-PEG-Ce6 nanoformulation is constructed for collaborative chemodynamic/phototherapy of tumors. Specifically, the Au2Pt nanozymes with multiple functions are synthesized in one step at room temperature. The photosensitizer chlorin e6 (Ce6) is covalently linked to Au2Pt nanozymes for photodynamic therapy (PDT). Interestingly, the Au2Pt nanozymes possess catalase- and peroxidase-like activities simultaneously, which not only can generate O-2 for relaxation of tumor hypoxia and enhancement of PDT efficiency but also can produce center dot OH for chemodynamic therapy (CDT). In addition, the high photothermal conversion efficiency (eta = 31.5%) of Au2Pt-PEG-Ce6 nanoformulation provides the possibility for photoacoustic (PA) and photothermal (PT) imaging guided photothermal therapy (PTT). Moreover, the presence of high-Z elements (Au and Pt) in Au2Pt-PEG-Ce6 nanoformulation endows it with the ability to act as an X-ray computed tomography (CT) imaging contrast agent. All in all, the Au2Pt-PEG-Ce6 exhibits great potential in multimodal imaging-guided synergistic PTT/PDT/CDT with remarkably tumor specificity and enhanced therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available